nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—Steatorrhoea—Azathioprine—rheumatoid arthritis	0.0419	0.0835	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Prednisolone—rheumatoid arthritis	0.0189	0.0376	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Dexamethasone—rheumatoid arthritis	0.0157	0.0313	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Betamethasone—rheumatoid arthritis	0.0157	0.0313	CcSEcCtD
Framycetin—Secondary infection—Azathioprine—rheumatoid arthritis	0.015	0.0298	CcSEcCtD
Framycetin—Nerve injury—Prednisolone—rheumatoid arthritis	0.0134	0.0266	CcSEcCtD
Framycetin—Malabsorption—Methotrexate—rheumatoid arthritis	0.0122	0.0243	CcSEcCtD
Framycetin—Ulcerative keratitis—Prednisolone—rheumatoid arthritis	0.0115	0.023	CcSEcCtD
Framycetin—Cataract subcapsular—Prednisolone—rheumatoid arthritis	0.0112	0.0223	CcSEcCtD
Framycetin—Nerve injury—Dexamethasone—rheumatoid arthritis	0.0111	0.0222	CcSEcCtD
Framycetin—Nerve injury—Betamethasone—rheumatoid arthritis	0.0111	0.0222	CcSEcCtD
Framycetin—Cataract subcapsular—Hydrocortisone—rheumatoid arthritis	0.0109	0.0217	CcSEcCtD
Framycetin—Cataract subcapsular—Triamcinolone—rheumatoid arthritis	0.0103	0.0205	CcSEcCtD
Framycetin—Cataract subcapsular—Methylprednisolone—rheumatoid arthritis	0.0103	0.0204	CcSEcCtD
Framycetin—Nephrotoxicity—Cyclosporine—rheumatoid arthritis	0.0101	0.0201	CcSEcCtD
Framycetin—Nerve injury—Prednisone—rheumatoid arthritis	0.00971	0.0193	CcSEcCtD
Framycetin—Secondary infection—Hydrocortisone—rheumatoid arthritis	0.00969	0.0193	CcSEcCtD
Framycetin—Eye infection—Prednisolone—rheumatoid arthritis	0.00941	0.0187	CcSEcCtD
Framycetin—Cataract subcapsular—Dexamethasone—rheumatoid arthritis	0.00932	0.0186	CcSEcCtD
Framycetin—Cataract subcapsular—Betamethasone—rheumatoid arthritis	0.00932	0.0186	CcSEcCtD
Framycetin—Secondary infection—Triamcinolone—rheumatoid arthritis	0.00913	0.0182	CcSEcCtD
Framycetin—Secondary infection—Methylprednisolone—rheumatoid arthritis	0.00911	0.0181	CcSEcCtD
Framycetin—Ulcerative keratitis—Prednisone—rheumatoid arthritis	0.00839	0.0167	CcSEcCtD
Framycetin—Secondary infection—Dexamethasone—rheumatoid arthritis	0.00828	0.0165	CcSEcCtD
Framycetin—Secondary infection—Betamethasone—rheumatoid arthritis	0.00828	0.0165	CcSEcCtD
Framycetin—Cataract subcapsular—Prednisone—rheumatoid arthritis	0.00812	0.0162	CcSEcCtD
Framycetin—Eye infection—Betamethasone—rheumatoid arthritis	0.00785	0.0156	CcSEcCtD
Framycetin—Eye infection—Dexamethasone—rheumatoid arthritis	0.00785	0.0156	CcSEcCtD
Framycetin—Impaired healing—Prednisolone—rheumatoid arthritis	0.00674	0.0134	CcSEcCtD
Framycetin—Impaired healing—Hydrocortisone—rheumatoid arthritis	0.00659	0.0131	CcSEcCtD
Framycetin—Impaired healing—Triamcinolone—rheumatoid arthritis	0.0062	0.0124	CcSEcCtD
Framycetin—Impaired healing—Methylprednisolone—rheumatoid arthritis	0.00619	0.0123	CcSEcCtD
Framycetin—Impaired healing—Dexamethasone—rheumatoid arthritis	0.00563	0.0112	CcSEcCtD
Framycetin—Impaired healing—Betamethasone—rheumatoid arthritis	0.00563	0.0112	CcSEcCtD
Framycetin—Nephropathy toxic—Cyclosporine—rheumatoid arthritis	0.00558	0.0111	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ENO1—rheumatoid arthritis	0.00508	0.0102	CbGpPWpGaD
Framycetin—Impaired healing—Prednisone—rheumatoid arthritis	0.0049	0.00976	CcSEcCtD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—FN1—rheumatoid arthritis	0.00478	0.00959	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL6—rheumatoid arthritis	0.00462	0.00927	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL10—rheumatoid arthritis	0.00459	0.00921	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—CXCL12—rheumatoid arthritis	0.00455	0.00914	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—BLK—rheumatoid arthritis	0.00447	0.00897	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCL21—rheumatoid arthritis	0.0044	0.00884	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—BDKRB2—rheumatoid arthritis	0.00415	0.00834	CbGpPWpGaD
Framycetin—Impaired healing—Methotrexate—rheumatoid arthritis	0.0041	0.00816	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PTPRC—rheumatoid arthritis	0.00399	0.00802	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL5—rheumatoid arthritis	0.00395	0.00793	CbGpPWpGaD
Framycetin—Glaucoma—Prednisolone—rheumatoid arthritis	0.00387	0.00772	CcSEcCtD
Framycetin—Glaucoma—Hydrocortisone—rheumatoid arthritis	0.00378	0.00754	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—CXCL12—rheumatoid arthritis	0.00375	0.00754	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—ADRBK1—rheumatoid arthritis	0.00371	0.00745	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.00367	0.00737	CbGpPWpGaD
Framycetin—Glaucoma—Triamcinolone—rheumatoid arthritis	0.00356	0.0071	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR5—rheumatoid arthritis	0.00356	0.00714	CbGpPWpGaD
Framycetin—Glaucoma—Methylprednisolone—rheumatoid arthritis	0.00355	0.00708	CcSEcCtD
Framycetin—Viral infection—Cyclosporine—rheumatoid arthritis	0.00355	0.00707	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.0035	0.00703	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT1—rheumatoid arthritis	0.00336	0.00676	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—rheumatoid arthritis	0.00333	0.00669	CbGpPWpGaD
Framycetin—Glaucoma—Betamethasone—rheumatoid arthritis	0.00323	0.00644	CcSEcCtD
Framycetin—Glaucoma—Dexamethasone—rheumatoid arthritis	0.00323	0.00644	CcSEcCtD
Framycetin—Viral infection—Prednisolone—rheumatoid arthritis	0.00323	0.00643	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.00322	0.00647	CbGpPWpGaD
Framycetin—Viral infection—Hydrocortisone—rheumatoid arthritis	0.00315	0.00628	CcSEcCtD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—rheumatoid arthritis	0.00304	0.00611	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PTK2—rheumatoid arthritis	0.00291	0.00585	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.00287	0.00577	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CCR5—rheumatoid arthritis	0.00285	0.00572	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—LEP—rheumatoid arthritis	0.00284	0.0057	CbGpPWpGaD
Framycetin—Glaucoma—Prednisone—rheumatoid arthritis	0.00281	0.00561	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.00279	0.00561	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL2—rheumatoid arthritis	0.00272	0.00546	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL13—rheumatoid arthritis	0.00272	0.00546	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—rheumatoid arthritis	0.0027	0.00542	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.00267	0.00536	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL21—rheumatoid arthritis	0.00267	0.00535	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NOS2—rheumatoid arthritis	0.00265	0.00531	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.00251	0.00504	CbGpPWpGaD
Framycetin—Nausea—Ergocalciferol—rheumatoid arthritis	0.00238	0.00474	CcSEcCtD
Framycetin—Viral infection—Prednisone—rheumatoid arthritis	0.00235	0.00467	CcSEcCtD
Framycetin—Pruritus—Auranofin—rheumatoid arthritis	0.00231	0.0046	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.0023	0.00461	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.0023	0.00461	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—HLA-DRB1—rheumatoid arthritis	0.00229	0.0046	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—C5—rheumatoid arthritis	0.00225	0.00453	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.00225	0.00452	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.00225	0.00451	CbGpPWpGaD
Framycetin—Diarrhoea—Auranofin—rheumatoid arthritis	0.00223	0.00445	CcSEcCtD
Framycetin—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.00222	0.00442	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.00216	0.00434	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—rheumatoid arthritis	0.00215	0.00432	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCR6—rheumatoid arthritis	0.00212	0.00426	CbGpPWpGaD
Framycetin—Vomiting—Auranofin—rheumatoid arthritis	0.00208	0.00413	CcSEcCtD
Framycetin—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00206	0.00411	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.00197	0.00395	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.00195	0.00392	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.00195	0.00392	CbGpPWpGaD
Framycetin—Nausea—Auranofin—rheumatoid arthritis	0.00194	0.00386	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL2—rheumatoid arthritis	0.00194	0.00389	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.00193	0.00387	CbGpPWpGaD
Framycetin—Vomiting—Penicillamine—rheumatoid arthritis	0.00192	0.00382	CcSEcCtD
Framycetin—CXCR4—HIV Infection—CD28—rheumatoid arthritis	0.00191	0.00383	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—SAA1—rheumatoid arthritis	0.0019	0.00381	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.00179	0.0036	CbGpPWpGaD
Framycetin—Nausea—Penicillamine—rheumatoid arthritis	0.00179	0.00357	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CCR5—rheumatoid arthritis	0.00175	0.00351	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.00173	0.00347	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.00169	0.00338	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—TGFB1—rheumatoid arthritis	0.00168	0.00336	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL12—rheumatoid arthritis	0.00165	0.00331	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—BDKRB2—rheumatoid arthritis	0.00165	0.00331	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00165	0.00331	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CD4—rheumatoid arthritis	0.00162	0.00324	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—rheumatoid arthritis	0.00158	0.00318	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.00158	0.00317	CbGpPWpGaD
Framycetin—Infection—Azathioprine—rheumatoid arthritis	0.00156	0.00311	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.00154	0.00309	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.00154	0.00309	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	0.00153	0.00308	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.00153	0.00307	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.00151	0.00303	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.00151	0.00303	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.00149	0.00298	CbGpPWpGaD
Framycetin—Anaphylactic shock—Leflunomide—rheumatoid arthritis	0.00148	0.00295	CcSEcCtD
Framycetin—Infection—Leflunomide—rheumatoid arthritis	0.00147	0.00293	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.00147	0.00295	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL10—rheumatoid arthritis	0.00146	0.00292	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.00143	0.00288	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—rheumatoid arthritis	0.00141	0.00282	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL21—rheumatoid arthritis	0.00137	0.00275	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—C5—rheumatoid arthritis	0.00136	0.00274	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.00134	0.00269	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.00131	0.00263	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.00131	0.00263	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.00131	0.00263	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR6—rheumatoid arthritis	0.00128	0.00258	CbGpPWpGaD
Framycetin—Erythema—Prednisolone—rheumatoid arthritis	0.00128	0.00254	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCL5—rheumatoid arthritis	0.00125	0.00252	CbGpPWpGaD
Framycetin—Erythema—Hydrocortisone—rheumatoid arthritis	0.00125	0.00248	CcSEcCtD
Framycetin—CXCR4—HIV Infection—CCR5—rheumatoid arthritis	0.00121	0.00243	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.0012	0.0024	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—HLA-A—rheumatoid arthritis	0.00118	0.00236	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.00117	0.00236	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL3—rheumatoid arthritis	0.00117	0.00236	CbGpPWpGaD
Framycetin—Erythema—Triamcinolone—rheumatoid arthritis	0.00117	0.00234	CcSEcCtD
Framycetin—Erythema—Methylprednisolone—rheumatoid arthritis	0.00117	0.00233	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.00116	0.00233	CbGpPWpGaD
Framycetin—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.00116	0.0023	CcSEcCtD
Framycetin—CXCR4—Disease—SYVN1—rheumatoid arthritis	0.00115	0.00232	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SAA1—rheumatoid arthritis	0.00115	0.0023	CbGpPWpGaD
Framycetin—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.00114	0.00228	CcSEcCtD
Framycetin—Infection—Cyclosporine—rheumatoid arthritis	0.00114	0.00226	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCR5—rheumatoid arthritis	0.00113	0.00227	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—C3—rheumatoid arthritis	0.0011	0.00222	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—CD4—rheumatoid arthritis	0.0011	0.00221	CbGpPWpGaD
Framycetin—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00109	0.00217	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.00109	0.00218	CbGpPWpGaD
Framycetin—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00107	0.00214	CcSEcCtD
Framycetin—Erythema—Betamethasone—rheumatoid arthritis	0.00106	0.00212	CcSEcCtD
Framycetin—Erythema—Dexamethasone—rheumatoid arthritis	0.00106	0.00212	CcSEcCtD
Framycetin—Pruritus—Leflunomide—rheumatoid arthritis	0.00105	0.00209	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.00105	0.0021	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.00105	0.0021	CbGpPWpGaD
Framycetin—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.00104	0.00207	CcSEcCtD
Framycetin—CXCR4—Disease—ACAN—rheumatoid arthritis	0.00103	0.00207	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.00102	0.00206	CbGpPWpGaD
Framycetin—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.00102	0.00202	CcSEcCtD
Framycetin—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00101	0.00202	CcSEcCtD
Framycetin—Infection—Hydrocortisone—rheumatoid arthritis	0.00101	0.00201	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.000998	0.002	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.000998	0.002	CbGpPWpGaD
Framycetin—Vomiting—Azathioprine—rheumatoid arthritis	0.000998	0.00199	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.000997	0.002	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC25A12—rheumatoid arthritis	0.000967	0.00194	CbGpPWpGaD
Framycetin—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000957	0.00191	CcSEcCtD
Framycetin—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000955	0.0019	CcSEcCtD
Framycetin—Infection—Triamcinolone—rheumatoid arthritis	0.000951	0.00189	CcSEcCtD
Framycetin—Infection—Methylprednisolone—rheumatoid arthritis	0.000949	0.00189	CcSEcCtD
Framycetin—Vomiting—Leflunomide—rheumatoid arthritis	0.000942	0.00188	CcSEcCtD
Framycetin—Nausea—Azathioprine—rheumatoid arthritis	0.000932	0.00186	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000931	0.00187	CbGpPWpGaD
Framycetin—Erythema—Prednisone—rheumatoid arthritis	0.000927	0.00185	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.000898	0.0018	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.000883	0.00177	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000882	0.00177	CbGpPWpGaD
Framycetin—Nausea—Leflunomide—rheumatoid arthritis	0.00088	0.00175	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.000878	0.00176	CbGpPWpGaD
Framycetin—CXCR4—Disease—PLB1—rheumatoid arthritis	0.000875	0.00176	CbGpPWpGaD
Framycetin—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000868	0.00173	CcSEcCtD
Framycetin—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000868	0.00173	CcSEcCtD
Framycetin—Infection—Betamethasone—rheumatoid arthritis	0.000863	0.00172	CcSEcCtD
Framycetin—Infection—Dexamethasone—rheumatoid arthritis	0.000863	0.00172	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000847	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000845	0.0017	CbGpPWpGaD
Framycetin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000843	0.00168	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.00081	0.00163	CbGpPWpGaD
Framycetin—Pruritus—Cyclosporine—rheumatoid arthritis	0.000809	0.00161	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL21—rheumatoid arthritis	0.000808	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000808	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Disease—RBPJ—rheumatoid arthritis	0.000807	0.00162	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000799	0.0016	CbGpPWpGaD
Framycetin—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000782	0.00156	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000775	0.00156	CbGpPWpGaD
Framycetin—Erythema—Methotrexate—rheumatoid arthritis	0.000774	0.00154	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—C5—rheumatoid arthritis	0.000771	0.00155	CbGpPWpGaD
Framycetin—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000767	0.00153	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000759	0.00152	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—rheumatoid arthritis	0.000759	0.00152	CbGpPWpGaD
Framycetin—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000756	0.00151	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000753	0.00151	CbGpPWpGaD
Framycetin—Infection—Prednisone—rheumatoid arthritis	0.000751	0.0015	CcSEcCtD
Framycetin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000749	0.00149	CcSEcCtD
Framycetin—Vomiting—Cyclosporine—rheumatoid arthritis	0.000727	0.00145	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000725	0.00146	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000725	0.00146	CbGpPWpGaD
Framycetin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000719	0.00143	CcSEcCtD
Framycetin—CXCR4—Disease—B3GNT2—rheumatoid arthritis	0.000713	0.00143	CbGpPWpGaD
Framycetin—CXCR4—Disease—ACP5—rheumatoid arthritis	0.000713	0.00143	CbGpPWpGaD
Framycetin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000705	0.0014	CcSEcCtD
Framycetin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000704	0.0014	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000702	0.00141	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—C5—rheumatoid arthritis	0.0007	0.00141	CbGpPWpGaD
Framycetin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000695	0.00139	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000687	0.00138	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000684	0.00137	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.000683	0.00137	CbGpPWpGaD
Framycetin—Nausea—Cyclosporine—rheumatoid arthritis	0.000679	0.00135	CcSEcCtD
Framycetin—Pruritus—Triamcinolone—rheumatoid arthritis	0.000677	0.00135	CcSEcCtD
Framycetin—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000676	0.00135	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—C3—rheumatoid arthritis	0.000668	0.00134	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000663	0.00133	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000659	0.00132	CbGpPWpGaD
Framycetin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000653	0.0013	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000649	0.0013	CbGpPWpGaD
Framycetin—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000646	0.00129	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000642	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Disease—BGN—rheumatoid arthritis	0.000642	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Disease—TLE3—rheumatoid arthritis	0.000642	0.00129	CbGpPWpGaD
Framycetin—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000632	0.00126	CcSEcCtD
Framycetin—Infection—Methotrexate—rheumatoid arthritis	0.000628	0.00125	CcSEcCtD
Framycetin—Nausea—Prednisolone—rheumatoid arthritis	0.000618	0.00123	CcSEcCtD
Framycetin—Pruritus—Betamethasone—rheumatoid arthritis	0.000614	0.00122	CcSEcCtD
Framycetin—Pruritus—Dexamethasone—rheumatoid arthritis	0.000614	0.00122	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PLB1—rheumatoid arthritis	0.000613	0.00123	CbGpPWpGaD
Framycetin—Vomiting—Triamcinolone—rheumatoid arthritis	0.000608	0.00121	CcSEcCtD
Framycetin—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000607	0.00121	CcSEcCtD
Framycetin—Nausea—Hydrocortisone—rheumatoid arthritis	0.000604	0.0012	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000602	0.00121	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000602	0.00121	CbGpPWpGaD
Framycetin—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000594	0.00118	CcSEcCtD
Framycetin—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000594	0.00118	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000589	0.00118	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC11A1—rheumatoid arthritis	0.000586	0.00118	CbGpPWpGaD
Framycetin—CXCR4—Disease—NFATC1—rheumatoid arthritis	0.000581	0.00117	CbGpPWpGaD
Framycetin—Nausea—Triamcinolone—rheumatoid arthritis	0.000568	0.00113	CcSEcCtD
Framycetin—Nausea—Methylprednisolone—rheumatoid arthritis	0.000567	0.00113	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000565	0.00114	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000564	0.00113	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000564	0.00113	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000558	0.00112	CbGpPWpGaD
Framycetin—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000557	0.00111	CcSEcCtD
Framycetin—Vomiting—Betamethasone—rheumatoid arthritis	0.000552	0.0011	CcSEcCtD
Framycetin—Vomiting—Dexamethasone—rheumatoid arthritis	0.000552	0.0011	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000543	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Disease—NCF2—rheumatoid arthritis	0.00054	0.00109	CbGpPWpGaD
Framycetin—Pruritus—Prednisone—rheumatoid arthritis	0.000535	0.00107	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—POMC—rheumatoid arthritis	0.000535	0.00107	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000526	0.00106	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000523	0.00105	CbGpPWpGaD
Framycetin—Diarrhoea—Prednisone—rheumatoid arthritis	0.000517	0.00103	CcSEcCtD
Framycetin—Nausea—Betamethasone—rheumatoid arthritis	0.000516	0.00103	CcSEcCtD
Framycetin—Nausea—Dexamethasone—rheumatoid arthritis	0.000516	0.00103	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000515	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000512	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000512	0.00103	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000506	0.00102	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000499	0.001	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000498	0.001	CbGpPWpGaD
Framycetin—CXCR4—Disease—SAA1—rheumatoid arthritis	0.000497	0.000998	CbGpPWpGaD
Framycetin—CXCR4—Disease—NCF1—rheumatoid arthritis	0.000487	0.000977	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO1—rheumatoid arthritis	0.000482	0.000967	CbGpPWpGaD
Framycetin—Vomiting—Prednisone—rheumatoid arthritis	0.000481	0.000958	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000478	0.000959	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD28—rheumatoid arthritis	0.000468	0.00094	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000467	0.000938	CbGpPWpGaD
Framycetin—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000466	0.000928	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000453	0.000909	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IRAK1—rheumatoid arthritis	0.00045	0.000903	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TLE3—rheumatoid arthritis	0.00045	0.000903	CbGpPWpGaD
Framycetin—Nausea—Prednisone—rheumatoid arthritis	0.000449	0.000895	CcSEcCtD
Framycetin—Pruritus—Methotrexate—rheumatoid arthritis	0.000447	0.000891	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000445	0.000894	CbGpPWpGaD
Framycetin—CXCR4—Disease—UBE2D1—rheumatoid arthritis	0.000441	0.000885	CbGpPWpGaD
Framycetin—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000432	0.000861	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000429	0.000861	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000428	0.00086	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADRBK1—rheumatoid arthritis	0.000427	0.000858	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000423	0.000849	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—C5—rheumatoid arthritis	0.000414	0.000831	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000414	0.00083	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000413	0.000829	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000407	0.000817	CbGpPWpGaD
Framycetin—Vomiting—Methotrexate—rheumatoid arthritis	0.000402	0.000801	CcSEcCtD
Framycetin—CXCR4—Disease—PRKCQ—rheumatoid arthritis	0.000394	0.000792	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL5—rheumatoid arthritis	0.00039	0.000782	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR6—rheumatoid arthritis	0.000389	0.000781	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT1—rheumatoid arthritis	0.000387	0.000778	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000387	0.000776	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000384	0.000771	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000381	0.000765	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCF2—rheumatoid arthritis	0.000378	0.00076	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—C3—rheumatoid arthritis	0.000378	0.000758	CbGpPWpGaD
Framycetin—Nausea—Methotrexate—rheumatoid arthritis	0.000375	0.000748	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000369	0.00074	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000369	0.00074	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GZMB—rheumatoid arthritis	0.000366	0.000736	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL3—rheumatoid arthritis	0.000356	0.000714	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000356	0.000714	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000351	0.000705	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SAA1—rheumatoid arthritis	0.000348	0.000699	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000346	0.000695	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—C3—rheumatoid arthritis	0.000343	0.000689	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCF1—rheumatoid arthritis	0.000341	0.000684	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CD28—rheumatoid arthritis	0.000328	0.000658	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000308	0.000619	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000303	0.000607	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000303	0.000607	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000302	0.000607	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.0003	0.000602	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000299	0.000601	CbGpPWpGaD
Framycetin—CXCR4—Disease—CCR5—rheumatoid arthritis	0.000296	0.000595	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—rheumatoid arthritis	0.000289	0.000581	CbGpPWpGaD
Framycetin—CXCR4—Disease—HLA-A—rheumatoid arthritis	0.000289	0.000579	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000282	0.000567	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SYK—rheumatoid arthritis	0.000281	0.000565	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000276	0.000554	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—rheumatoid arthritis	0.000274	0.000551	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT1—rheumatoid arthritis	0.000271	0.000545	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000268	0.000539	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000268	0.000537	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000267	0.000537	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6ST—rheumatoid arthritis	0.000253	0.000508	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—rheumatoid arthritis	0.000251	0.000504	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP3—rheumatoid arthritis	0.000244	0.00049	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000244	0.000489	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD80—rheumatoid arthritis	0.000244	0.000489	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTK2—rheumatoid arthritis	0.000235	0.000471	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000234	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL5—rheumatoid arthritis	0.00023	0.000462	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CSF2—rheumatoid arthritis	0.000227	0.000455	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6R—rheumatoid arthritis	0.000226	0.000453	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000223	0.000448	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—rheumatoid arthritis	0.000213	0.000428	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000212	0.000426	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR5—rheumatoid arthritis	0.000207	0.000416	CbGpPWpGaD
Framycetin—CXCR4—Disease—TYK2—rheumatoid arthritis	0.000206	0.000413	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000204	0.00041	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—rheumatoid arthritis	0.000203	0.000407	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—C3—rheumatoid arthritis	0.000203	0.000407	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—rheumatoid arthritis	0.000202	0.000405	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—rheumatoid arthritis	0.000189	0.000379	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—rheumatoid arthritis	0.000186	0.000373	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—rheumatoid arthritis	0.000185	0.000371	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FN1—rheumatoid arthritis	0.000178	0.000357	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000177	0.000356	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CD80—rheumatoid arthritis	0.000171	0.000342	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—rheumatoid arthritis	0.000162	0.000325	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL2—rheumatoid arthritis	0.000159	0.000318	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6R—rheumatoid arthritis	0.000158	0.000317	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TYK2—rheumatoid arthritis	0.000144	0.000289	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—rheumatoid arthritis	0.000141	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—rheumatoid arthritis	0.000133	0.000268	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—rheumatoid arthritis	0.000125	0.000252	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—rheumatoid arthritis	0.00012	0.000241	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—rheumatoid arthritis	0.000119	0.000239	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—rheumatoid arthritis	0.000113	0.000228	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000112	0.000225	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—rheumatoid arthritis	0.00011	0.000221	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—rheumatoid arthritis	0.000102	0.000204	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—rheumatoid arthritis	0.000101	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—rheumatoid arthritis	9.34e-05	0.000188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—rheumatoid arthritis	7.69e-05	0.000154	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—rheumatoid arthritis	7.04e-05	0.000141	CbGpPWpGaD
